Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2025
상품코드:1825630
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 연평균 성장률(CAGR)은 6.4%를 나타낼 것으로 예측되고 1,267억 6,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 질병 유병률 증가, 의료 분야 IT 통합, 정부 정책 및 자금 지원, 맞춤형 의약품으로의 전환, 의료 제공자들 사이에서 진단 분야 생물정보학의 이점에 대한 인식 향상, 그리고 게놈 시퀀싱 비용 감소 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 인공지능(AI) 및 머신 러닝, 차세대 시퀀싱(NGS), 현장 진단(POC) 시험, 클라우드 컴퓨팅 및 빅데이터, 면역화학 기술의 혁신 등이 포함된다.
향후 5년간 6.4% 성장이라는 예측치는 해당 시장에 대한 이전 추정치 대비 0.4% 소폭 하향 조정된 수치이다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 분쟁의 영향 때문이다. 무역 긴장은 프랑스와 중국에서 개발된 차세대 시퀀싱(NGS) 데이터 분석 도구 및 머신 러닝 알고리즘의 가격 상승을 유발하여 미국 진단 정확도를 저해할 수 있으며, 이는 검사 결과 지연과 분자병리학 실험실 비용 증가로 이어질 수 있습니다. 또한 상호 관세 부과와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.
암 유병률 증가로 인해 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 성장이 촉진될 것으로 전망됩니다. 암은 주변 조직을 침범하고 신체 다른 부위로 전이될 수 있는 비정상적인 세포 증식으로 특징지어지는 질병군을 의미합니다. 생활 방식, 환경적 영향, 노출 위험 등 다양한 요인이 암 유병률 증가에 기여합니다. 체외 진단(IVD) 검사 분야 바이오인포매틱스는 정확한 맞춤형 유전적 통찰력을 제공함으로써 암 진단을 혁신하고 있으며, 이는 조기 발견을 개선하고 치료 결정을 안내하며 환자 결과를 향상시킵니다. 예를 들어, 2022년 미국 정부 기관인 만성질환국장협회(NACDD)는 미국 성인의 약 40%가 다중 만성질환(MCC)을 앓고 있다고 보고했습니다. 또한 한 가지 만성질환을 앓고 있으면 특히 나이가 들수록 추가 질환 발병 가능성이 높아진다는 데이터도 제시했습니다. 결과적으로 암 유병률 증가가 체외 진단(IVD) 검사 분야 바이오인포매틱스 수요를 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 성장률 분석
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 실적 : 규모와 성장(2019-2024년)
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
하드웨어
소프트웨어
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 검사 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈액검사
조직 기반 검사
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 용도별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
심혈관 질환
만성 질환
당뇨병
암
기타 용도
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장, 하드웨어 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
분석기
실험장치
데이터 저장 장치
센서 및 검출기
워크스테이션 및 데이터 처리 하드웨어
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장, 소프트웨어 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
바이오인포매틱스 플랫폼
데이터 관리 및 통합 소프트웨어
분석 및 해석 소프트웨어
클라우드 기반 소프트웨어 솔루션
진단용 AI 기반 소프트웨어
제7장 지역별 및 국가별 분석
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 경쟁 구도
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장 : 기업 프로파일
Siemens Healthineers : 개요, 제품 및 서비스, 전략 및 재무 분석
International Business Machines Corporation : 개요, 제품 및 서비스, 전략 및 재무 분석
Medtronic Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Parker Hannifin Corp. : 개요, 제품 및 서비스, 전략 및 재무 분석
Illumina Inc : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
PerkinElmer Inc.
QIAGEN NV
Kollmorgen Corp
Bioreference Laboratories Inc.
AssureRx Health Inc.
Biodesix Inc.
Crescendo Bioscience Inc.
Affymetrix
Complete Genomics Inc.
Aperico Technologies Inc.
One Lambda Inc.
Datech Oncology
Life Technologies
Signal genetics
CardioDx Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 새로운 기회를 제공하는 국가
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 새로운 기회를 제공하는 부문
체외 진단(IVD) 검사 분야 바이오인포매틱스 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Bioinformatics in in vitro diagnostics (IVD) involves applying computational methods, data analysis, and software tools to interpret biological data from diagnostic tests conducted outside the living organism. This includes using algorithms and statistical models to process large volumes of molecular and clinical data.
In the realm of bioinformatics in IVD testing, hardware encompasses the physical components and devices used in laboratory and computational settings. These tests, which include blood-based and tissue-based assays, find applications in detecting conditions such as cardiovascular diseases, chronic illnesses, diabetes, cancer, among others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The bioinformatics in IVD testing market research report is one of a series of new reports from The Business Research Company that provides bioinformatics in IVD testing market statistics, including bioinformatics in IVD testing industry global market size, regional shares, competitors with bioinformatics in IVD testing market share, detailed bioinformatics in IVD testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bioinformatics in IVD testing industry. This bioinformatics in IVD testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics in in-vitro diagnostics (ivd) testing market size has grown strongly in recent years. It will grow from $93.02 billion in 2024 to $98.89 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to improved healthcare infrastructure, expansion of biobanks, rising geriatric population, government initiatives and funding, and growth of personalized medicine.
The bioinformatics in in-vitro diagnostics (ivd) testing market size is expected to see strong growth in the next few years. It will grow to $126.76 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to rising prevalence of diseases, integration of IT in healthcare, government initiatives and funding, the shift towards personalized medicine, enhanced awareness about the benefits of bioinformatics in diagnostics among healthcare providers, and the decreasing cost of genomic sequencing. Major trends in the forecast period include artificial intelligence (AI) and machine learning, next-generation sequencing, point-of-care (POC) testing, cloud computing and big data, and innovations in immunochemical techniques.
The forecast of 6.4% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. diagnostic accuracy by inflating prices of Next-Generation Sequencing(NGS) data analysis tools and machine learning algorithms developed in France and China, resulting in delayed test results and higher molecular pathology lab expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising prevalence of cancer is expected to drive growth in the bioinformatics in IVD (in vitro diagnostics) testing market. Cancer refers to a group of diseases marked by abnormal cell growth, which can invade surrounding tissues and spread to other parts of the body. Various factors, including lifestyle, environmental influences, and exposure risks, contribute to the increasing prevalence of cancer. Bioinformatics in IVD testing is transforming cancer diagnostics by providing precise, personalized genetic insights that improve early detection, guide treatment decisions, and enhance patient outcomes. For instance, in 2022, the National Association of Chronic Disease Directors (NACDD), a U.S.-based government agency, reported that approximately 40% of American adults live with multiple chronic conditions (MCC). The data also shows that having one chronic illness increases the likelihood of developing additional conditions, particularly with age. As a result, the growing prevalence of cancer is fueling demand for bioinformatics in the IVD testing market.
Leading companies in this market are focused on innovation, particularly in next-generation sequencing (NGS) technology. NGS enables rapid sequencing of entire genomes or specific DNA and RNA regions, facilitating comprehensive genetic analysis. For example, in May 2022, Illumina Inc. introduced a pan-cancer companion diagnostic (CDx) indication for its CE-marked TruSight Oncology Comprehensive (EU) test. This test identifies cancer patients with solid tumors harboring neurotrophic tyrosine receptor kinase (NTRK) gene fusions (NTRK1, NTRK2, or NTRK3), who may benefit from targeted therapy with Bayer's Vitrakvi (larotrectinib). The TSO Comprehensive (EU) test employs comprehensive genomic profiling (CGP), using next-generation sequencing to analyze multiple tumor genes and biomarkers from a single biopsy specimen, thereby determining each patient's specific cancer molecular profile.
In September 2024, QIAGEN N.V., a Germany-based molecular diagnostics company, partnered with Eli Lilly and Company to develop the first in vitro diagnostic (IVD) test for APOE genotyping, specifically for Alzheimer's disease, utilizing QIAGEN's QIAstat-Dx platform. This collaboration represents a significant advancement in neurodegenerative disease diagnostics, expanding QIAGEN's clinical applications and partnerships in diagnostic development. Eli Lilly and Company, a U.S.-based pharmaceutical firm, specializes in in vitro diagnostics (IVD) testing.
Major companies operating in the bioinformatics in in-vitro diagnostics (IVD) testing market are Siemens Healthineers, International Business Machines Corporation, Medtronic Inc., Parker Hannifin Corp., Illumina Inc, PerkinElmer Inc., QIAGEN N.V., Kollmorgen Corp, Bioreference Laboratories Inc., AssureRx Health Inc., Biodesix Inc., Crescendo Bioscience Inc., Affymetrix, Complete Genomics Inc., Aperico Technologies Inc., One Lambda Inc., Datech Oncology, Life Technologies, Signal genetics, CardioDx Inc.
North America was the largest region in the bioinformatics in in-vitro diagnostics (IVD) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bioinformatics in in-vitro diagnostics (IVD) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bioinformatics in in-vitro diagnostics (IVD) testing market consists of revenues earned by entities by providing services such as clinical decision support systems, sequence analysis, and clinical genomics software. The market value includes the value of related goods sold by the service provider or included within the service offering. The bioinformatics in in vitro diagnostics (IVD) testing market also includes sales of sequencing tools and diagnostics tools. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bioinformatics In In-Vitro Diagnostics (IVD) Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bioinformatics in in-vitro diagnostics (ivd) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bioinformatics in in-vitro diagnostics (ivd) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bioinformatics in in-vitro diagnostics (ivd) testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Hardware; Software
2) By Type Of Test: Blood Based Tests; Tissue Based Tests
3) By Application: Cardiovascular Diseases; Chronic Diseases; Diabetes; Cancer; Other Applications
Subsegments:
1) By Hardware: Analyzers; Laboratory Equipment; Data Storage Devices; Sensors And Detectors; Workstations And Data Processing Hardware
2) By Software: Bioinformatics Platforms; Data Management and Integration Software; Analytics And Interpretation Software; Cloud-Based Software Solutions; AI-Based Software For Diagnostics
Companies Mentioned: Siemens Healthineers; International Business Machines Corporation; Medtronic Inc.; Parker Hannifin Corp.; Illumina Inc; PerkinElmer Inc.; QIAGEN N.V.; Kollmorgen Corp; Bioreference Laboratories Inc.; AssureRx Health Inc.; Biodesix Inc.; Crescendo Bioscience Inc.; Affymetrix; Complete Genomics Inc.; Aperico Technologies Inc.; One Lambda Inc.; Datech Oncology; Life Technologies; Signal genetics; CardioDx Inc.
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Characteristics
3. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Trends And Strategies
4. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Growth Rate Analysis
5.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Total Addressable Market (TAM)
6. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Segmentation
6.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hardware
Software
6.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Based Tests
Tissue Based Tests
6.3. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cardiovascular Diseases
Chronic Diseases
Diabetes
Cancer
Other Applications
6.4. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Analyzers
Laboratory Equipment
Data Storage Devices
Sensors And Detectors
Workstations And Data Processing Hardware
6.5. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Bioinformatics Platforms
Data Management and Integration Software
Analytics And Interpretation Software
Cloud-Based Software Solutions
AI-Based Software For Diagnostics
7. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Regional And Country Analysis
7.1. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
8.1. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
9.1. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
9.2. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
10.1. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
11.1. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
11.2. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
12.1. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
13.1. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
14.1. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
14.2. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
15.1. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
15.2. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
16.1. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
17.1. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
18.1. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
19.1. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
20.1. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
21.1. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
21.2. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
22.1. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
23.1. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
23.2. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
24.1. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
24.2. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
25.1. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
25.2. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
26.1. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
26.2. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
27.1. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
28.1. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
28.2. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
29.1. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Overview
29.2. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Type Of Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape And Company Profiles
30.1. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Landscape
30.2. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Company Profiles
30.2.1. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
30.2.2. International Business Machines Corporation Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Medtronic Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Parker Hannifin Corp. Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Illumina Inc Overview, Products and Services, Strategy and Financial Analysis
31. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Other Major And Innovative Companies
31.1. PerkinElmer Inc.
31.2. QIAGEN N.V.
31.3. Kollmorgen Corp
31.4. Bioreference Laboratories Inc.
31.5. AssureRx Health Inc.
31.6. Biodesix Inc.
31.7. Crescendo Bioscience Inc.
31.8. Affymetrix
31.9. Complete Genomics Inc.
31.10. Aperico Technologies Inc.
31.11. One Lambda Inc.
31.12. Datech Oncology
31.13. Life Technologies
31.14. Signal genetics
31.15. CardioDx Inc.
32. Global Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
34. Recent Developments In The Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market
35. Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market High Potential Countries, Segments and Strategies
35.1 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Bioinformatics In In-Vitro Diagnostics (IVD) Testing Market In 2029 - Growth Strategies
